Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013

doi:10.3748/wjg.v20.i40.14581

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 40

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7743)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

532

WORD

293

HTML

3357

Tables (1-2)

137

Sum=4319

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

595

Download

710

Sum=1305

Publishing Process of This Article

Item

Count

Browse

1161

Download

958

Sum=2119

Oct 28, 2014 (publication date) through Apr 23, 2024

Times Cited of This Article

Times Cited (26)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 28, 2014; 20(40): 14581-14588
Published online Oct 28, 2014. doi: 10.3748/wjg.v20.i40.14581

Table 1 Risk factors for anticancer chemotherapy-related hepatitis B virus reactivation

Categories	Risk factors	Ref.
Host factors	Male gender Young age Elevated baseline ALT	[8] [8] [63]
Tumor- or treatment-related factors	Lymphoma Hematologic malignancies Brease cancer Glucocorticoid use Anthracycline use Rituximab-based regimen Hematopoietic stem cell transplantation	[6,8] [8,64] [6] [6,16] [6] [17,29] [65]
Viral factors	High pre-chemotherapy viral load Positive HBeAg Presence of precore mutant Negative or low titer of HBsAb (in case of occult/past infection)	[66] [8,67] [25,68] [17]

ALT: Alanine aminotransferase; HBeAg: Hepatitis B e antigen; HBsAb: Hepatitis B surface antibody.

Citation: Kim HY, Kim W. Chemotherapy-related reactivation of hepatitis B infection: Updates in 2013. World J Gastroenterol 2014; 20(40): 14581-14588
URL: https://www.wjgnet.com/1007-9327/full/v20/i40/14581.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i40.14581